Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study

Publisher： Karger

E-ISSN： 1423-0216|19|5|277-282

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.19, Iss.5, 2012-03, pp. : 277-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease

By  

Neuroimmunomodulation, Vol. 23, Iss. 1, 2015-11 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study

By  

Neuroimmunomodulation, Vol. 20, Iss. 4, 2013-05 ,pp. : 213-222

Karger

Access to resources Recommend Favorite

TRAF2 is Upregulated in Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 20, Iss. 3, 2013-04 ,pp. : 177-183

Karger

Access to resources Recommend Favorite

CCL5, CXCL10 and CXCL11 Chemokines in Patients with Active and Stable Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 18, Iss. 1, 2010-08 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Severe Disability in Patients with Relapsing-Remitting Multiple Sclerosis Is Associated with Profound Changes in the Regulation of Leptin Secretion

By  

Neuroimmunomodulation, Vol. 20, Iss. 6, 2013-08 ,pp. : 341-347

Karger

Access to resources Recommend Favorite